An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation

Journal of Controlled Release

Volumn 143, Issue 1, 2010, Pages 13-22

  Paoli, E E ^a   Kruse, D E ^a   Seo, J W ^a   Zhang, H ^a   Kheirolomoom, A ^a   Watson, K D ^a   Chiu, P ^b   Stahlberg, H ^b,c   Ferrara, K W ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Image guided drug delivery; NIR imaging; Temperature sensitive liposomes

Indexed keywords

IMAGE-GUIDED; IMAGE-GUIDED DRUG DELIVERY; NIR IMAGING; TEMPERATURE-SENSITIVE;

ELECTRON MICROSCOPES; FLUORESCENCE; HYDROPHILICITY; IMAGING TECHNIQUES; INFRARED DEVICES; LIPOSOMES; PHOSPHOLIPIDS; SCANNING ELECTRON MICROSCOPY; TUMORS;

CONTROLLED DRUG DELIVERY;

1 PALMITOYL 2 HYDROXY SN GLYCERO 3 PHOSPHATIDYLCHOLINE; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [METHOXY (POLYETHYLENEGLYCOL) 2000]; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; DRUG; LIPOSOME; MACROGOL 2000; N PALMITOYL SPHINGOSINE 1 [SUCCINYL(METHOXYPOLYETHYLENEGLYCOL) 2000]; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CELL STRAIN MET 1; CONTROLLED STUDY; DIGITAL IMAGING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STABILITY; ELECTRON MICROSCOPY; ENCAPSULATION; FEMALE; HYDROPHILICITY; KINETICS; MOUSE; NONHUMAN; OSMOLARITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CRYOELECTRON MICROSCOPY; DRUG COMPOUNDING; FEMALE; FLUORESCEINS; FLUORESCENT DYES; INJECTIONS, INTRAVENOUS; LIPIDS; LIPOSOMES; MAMMARY NEOPLASMS, ANIMAL; MICE; PARTICLE SIZE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; SUCCINIMIDES; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 77950518551     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.12.010     Document Type: Article

References (50)

1. Ponce A.M., Viglianti B.L., Yu D.H., Yarmolenko P.S., Michelich C.R., Woo J., Bally M.B., Dewhirst M.W. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. Journal of the National Cancer Institute 2007, 99(1):53-63.
2. Dromi S., Frenkel V., Luk A., Traughber B., Angstadt M., Bur M., Poff J., Xie J.W., Libutti S.K., Li K.C.P., Wood B.J. Pulsed-high intensity focused ultrasound and low temperature sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clinical Cancer Research 2007, 13(9):2722-2727.
3. Derfus A.M., von Maltzahn G., Harris T.J., Duza T., Vecchio K.S., Ruoslahti E., Bhatia S.N. Remotely triggered release from magnetic nanoparticles. Advanced Materials 2007, 19(22):3932-3936.
4. Gannon C.J., Patra C.R., Bhattacharya R., Mukherjee P., Curley S.A. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. Journal of Nanobiotechnology 2008, 6. Article No.: 2.
5. Schroeder A., Honen R., Turjeman K., Gabizon A., Kost J., Barenholz Y. Ultrasound triggered release of cisplatin from liposomes in murine tumors. Journal of Controlled Release 2009, 137(1):63-68.
6. Kim I.-Y., Kang Y.-S., Lee D.S., Park H.-J., Choi E.-K., Oh Y.-K., Son H.-J., Kim J.-S. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. Journal of Controlled Release 2009, 140(1):55-60.
7. P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Döblinger, R. Banerjee, D. Bahadur, C. Plank, Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. Journal of Controlled Release. In Press, Corrected Proof.
8. Dewhirst M.W., Vujaskovic Z., Jones E., Thrall D. Re-setting the biologic rationale for thermal therapy. International Journal of Hyperthermia 2005, 21(8):779-790.
9. Safra T., Muggia F., Jeffers S., Tsao-Wei D.D., Groshen S., Lyass O., Henderson R., Berry G., Gabizon A. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500mg/m(2). Annals of Oncology 2000, 11(8):1029-1033.
10. Yildirim Y., Gultekin E., Avci M.E., Inal M.M., Yunus S., Tinar S. Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550mg/m(2) in patients with recurrent ovarian and peritoneal cancer. International Journal of Gynecological Cancer 2008, 18(2):223-227.
11. Olson F., Mayhew E., Maslow D., Rustum Y., Szoka F. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. European Journal of Cancer & Clinical Oncology 1982, 18(2):167-169.
12. Kong G., Anyarambhatla G., Petros W.P., Braun R.D., Colvin O.M., Needham D., Dewhirst M.W. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Research 2000, 60(24):6950-6957.
13. Choi S.H., Lee S.H., Park T.G. Temperature-sensitive pluronic/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment. Biomacromolecules 2006, 7(6):1864-1870.
14. Han H.D., Choi M.S., Hwang T., Song C.K., Seong H., Kim T.W., Choi H.S., Shin B.C. Hyperthermia-induced antitumor activity of thermosensitive polymer modified temperature-sensitive liposomes. Journal of Pharmaceutical Sciences 2006, 95(9):1909-1917.
15. Hauck M.L., Larue S.M., Petros W.P., Poulson J.M., Yu D.H., Spasojevic I., Pruitt A.F., Klein A., Case B., Thrall D.E., Needha D., Dewhirst M.W. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clinical Cancer Research 2006, 12(13):4004-4010.
16. Schmaljohann D. Thermo- and pH-responsive polymers in drug delivery. Advanced Drug Delivery Reviews 2006, 58(15):1655-1670.
17. Seo J.W., Zhang H., Kukis D.L., Meares C.F., Ferrara K.W. A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging. Bioconjugate Chemistry 2008, 19(12):2577-2584.
18. Shim W.S., Kim J.H., Kim K., Kim Y.S., Park R.W., Kim I.S., Kwon I.C., Lee D.S. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. International Journal of Pharmaceutics 2007, 331(1):11-18.
19. http://www.traxtal.com/home.html.
20. Mills J.K., Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochimica Et Biophysica Acta-Biomembranes 2005, 1716(2):77-96.
21. Lencioni R., Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008, 66(3):200-207.
22. Chen X., Barkauskas K.J., Weinberg B.D., Duerk J.L., Abdul-Karim F.W., Paul S., Saidel G.M. Dynamics of MRI-guided thermal ablation of VX2 tumor in paraspinal muscle of rabbits. IEEE Transactions on Biomedical Engineering 2008, 55:1004-1014.
23. Yap J.T., Carney J.P.J., Hall N.C., Townsend D.W. Image-guided cancer therapy using PET/CT. Cancer Journal 2004, 10(4):221-233.
24. Bale R., Widmann G. Navigated CT-guided interventions. Minimally Invasive Therapy & Allied Technologies 2007, 16(4):196-204.
25. Marik J., Tartis M.S., Zhang H., Fung J.Y., Kheirolomoom A., Sutcliffe J.L., Ferrara K.W. Long-circulating liposomes radiolabeled with [F-18]fluorodipalmitin ([F-18]FDP). Nuclear Medicine and Biology 2007, 34(2):165-171.
26. Heyes J., Hall K., Tailor V., Lenz R., MacLachlan I. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. Journal of Controlled Release 2006, 112(2):280-290.
27. Drummond D.C., Noble C.O., Guo Z.X., Hong K., Park J.W., Kirpotin D.B. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Research 2006, 66(6):3271-3277.
28. Lee R.J., Low P.S. Folate-targeted liposomes for drug delivery. Journal of Liposome Research 1997, 7(4):455-466.
29. Allen T.M., Cleland L.G. Serum-induced leakage of liposome contents. Biochimica Et Biophysica Acta 1980, 597(2):418-426.
30. Terreno E., Cabella C., Carrera C., Castelli D.D., Mazzon R., Rollet S., Stancanello J., Visigalli M., Aime S. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons. Angewandte Chemie-International Edition 2007, 46(6):966-968.
31. Hope M.J., Bally M.B., Webb G., Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size, trapped volume and ability to maintain a membrane potential. Biochimica Et Biophysica Acta-Biomembranes 1985, 812(1):55-65.
32. Gregoriadis G. Liposome Technology 1984, CRC Press, Boca Raton, Fla.
33. Wang L., Yao Q., Wang J., Wei G.Q., Li G.Q., Li D., Ling R., Chen J.H. MRI and hybrid PET/CT for monitoring tumour metastasis in a metastatic breast cancer model in rabbit. Nuclear Medicine Communications 2008, 29(2):137-143.
34. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary-tumors by expression of polyomavirus middle T-oncogene-a transgenic mouse model for metastatic disease. Molecular and Cellular Biology 1992, 12(3):954-961.
35. Yu C., Penn L.D., Hollembaek J., Li W.L., Cohen L.H. Enzymatic tissue digestion as an alternative sample preparation approach for quantitative analysis using liquid chromatography-tandem mass spectrometry. Analytical Chemistry 2004, 76(6):1761-1767.
36. Dubochet J., Adrian M., Chang J.-J., Homo J.-C., Lepault J., McDowall A.W., Schultz P. Cryo-electron microscopy of vitrified specimens. Quarter Review Biophysics 1988, 21:129-228.
37. Working P.K., Dayan A.D. Pharmacological-toxicological expert report-caelyx(TM)-(stealth(R) liposomal doxorubicin HCl)-foreword. Human & Experimental Toxicology 1996, 15(9):751-785.
38. Gaber M.H., Hong K.L., Huang S.K., Papahadjopoulos D. Thermosensitive sterically stabilized liposomes-formulation and in-vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharmaceutical Research 1995, 12(10):1407-1416.
39. Needham D., Anyarambhatla G., Kong G., Dewhirst M.W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Research 2000, 60(5):1197-1201.
40. Webb M.S., Saxon D., Wong F.M.P., Lim H.J., Wang Z., Bally M.B., Choi L.S.L., Cullis P.R., Mayer L.D. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochimica Et Biophysica Acta-Biomembranes 1998, 1372(2):272-282.
41. Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978, 202(4374):1290-1293.
42. Matsumura S., Sato S., Yudasaka M., Tomida A., Tsruruo T., Iijima S., Shiba K. Prevention of carbon nanohorn agglomeration using a conjugate composed of comb-shaped polyethylene glycol and a peptide aptamer. Molecular Pharmaceutics 2009, 6(2):441-447.
43. Zhang H., Kusunose J., Kheirolomoom A., Seo J.W., Qi J., Watson K., Lindfors H., Ruoslahti E., Sutcliffe J.L., Ferrara K.W. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials 2008, 29(12):1976-1988.
44. Hossann M., Wiggenhorn M., Schwerdt A., Wachholz K., Teichert N., Eibl H., Issels R.D., Lindner L.H. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochimica Et Biophysica Acta-Biomembranes 2007, 1768(10):2491-2499.
45. S. Qin, J.W. Seo, H. Zhang, J. Qi, F.-R.E. Curry, K.W. Ferrara, An imaging-driven model for liposomal stability and circulation. Molecular Pharmaceutics (In Press, Accepted Manuscript).
46. Charrois G.J.R., Allen T.M. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochimica Et Biophysica Acta-Biomembranes 2004, 1663(1-2):167-177.
47. Woo J., Chiu G.N.C., Karlsson G., Wasan E., Ickenstein L., Edwards K., Bally M.B. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermo sensitive liposomes. International Journal of Pharmaceutics 2008, 349(1-2):38-46.
48. Drummond D.C., Noble C.O., Hayes M.E., Park J.W., Kirpotin D.B. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. Journal of Pharmaceutical Sciences 2008, 97(11):4696-4740.
49. Abu-Lila A., Suzuki T., Doi Y., Ishida T., Kiwada H. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model. Journal of Controlled Release 2009, 134(1):18-25.
50. Mai J., Song S., Rui M., Liu D., Ding Q., Peng J., Xu Y. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Journal of Controlled Release 2009, 139(3):174-181.